What we do.

We develop therapies that can switch immunity on/off to help people

with significant illnesses receive life-altering treatments

LAPIX is an Immune System Modulation Company with 2 Distinct Therapeutic Pipelines

By Binding to A Key Immune Checkpoint, LAPIX Therapies Re-Educate the Immune System to Attack Foes and Tolerate Self/Friends

Our Platforms Act Like Modulators of a Single Volume Knob that Turns Immunity Up or Down

LAPIX Has Strong Pre-Clinical Data to Support the Development of 2 Immuno-Modulatory Platforms Targeting 3 Areas of Disease with a Single Setup

 
Icon-1.png
 

LAPIX-IO

Multi-Checkpoint Inhibitor

• For Immune Oncology

Icon-2.png
 

LAPIX-TI

Check Point Activator for Immune Tolerance Induction

• For Autoimmune Disorders

• For Enzyme Replacement Therapy and Gene Therapy

We’re Working to Help

Treatment-Patients-01.png

Children who need Gene Therapy or ERT

Treatment-Patients.png

Cancer Patients

Treatment-Patients-03.png

Individuals with Autoimmune Diseases

 

We help by targeting therapies that delay onset of disease, sustain response, or make partner drugs safer

 

Careers

Interested in working with Lapix? Let’s talk.